These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34696413)

  • 1. Xeno-Nucleic Acid (XNA) 2'-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding.
    Alves Ferreira-Bravo I; DeStefano JJ
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xeno-nucleic Acid (XNA) 2'-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding.
    Ferreira-Bravo IA; DeStefano JJ
    bioRxiv; 2021 Jul; ():. PubMed ID: 34282416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing Aptamers Block S/RBD-ACE2 Interactions and Prevent Host Cell Infection.
    Liu X; Wang YL; Wu J; Qi J; Zeng Z; Wan Q; Chen Z; Manandhar P; Cavener VS; Boyle NR; Fu X; Salazar E; Kuchipudi SV; Kapur V; Zhang X; Umetani M; Sen M; Willson RC; Chen SH; Zu Y
    Angew Chem Int Ed Engl; 2021 Apr; 60(18):10273-10278. PubMed ID: 33684258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SARS-CoV-2 Spike Binding DNA Aptamer that Inhibits Pseudovirus Infection by an RBD-Independent Mechanism*.
    Schmitz A; Weber A; Bayin M; Breuers S; Fieberg V; Famulok M; Mayer G
    Angew Chem Int Ed Engl; 2021 Apr; 60(18):10279-10285. PubMed ID: 33683787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection.
    Sun M; Liu S; Wei X; Wan S; Huang M; Song T; Lu Y; Weng X; Lin Z; Chen H; Song Y; Yang C
    Angew Chem Int Ed Engl; 2021 Apr; 60(18):10266-10272. PubMed ID: 33561300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serum-stable RNA aptamer specific for SARS-CoV-2 neutralizes viral entry.
    Valero J; Civit L; Dupont DM; Selnihhin D; Reinert LS; Idorn M; Israels BA; Bednarz AM; Bus C; Asbach B; Peterhoff D; Pedersen FS; Birkedal V; Wagner R; Paludan SR; Kjems J
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
    David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
    Molecules; 2021 May; 26(11):. PubMed ID: 34072087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants.
    Tanaka S; Nelson G; Olson CA; Buzko O; Higashide W; Shin A; Gonzalez M; Taft J; Patel R; Buta S; Richardson A; Bogunovic D; Spilman P; Niazi K; Rabizadeh S; Soon-Shiong P
    Sci Rep; 2021 Jun; 11(1):12740. PubMed ID: 34140558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of SARS-CoV-2 infection in human airway epithelium with a xeno-nucleic acid aptamer.
    Razi N; Li W; Ignacio MA; Loube JM; Agostino EL; Zhu X; Scull MA; DeStefano JJ
    Respir Res; 2023 Nov; 24(1):272. PubMed ID: 37932762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
    Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
    J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common cardiac medications potently inhibit ACE2 binding to the SARS-CoV-2 Spike, and block virus penetration and infectivity in human lung cells.
    Caohuy H; Eidelman O; Chen T; Liu S; Yang Q; Bera A; Walton NI; Wang TT; Pollard HB
    Sci Rep; 2021 Nov; 11(1):22195. PubMed ID: 34773067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach.
    Silwal AP; Thennakoon SKS; Arya SP; Postema RM; Jahan R; Phuoc CMT; Tan X
    Theranostics; 2022; 12(12):5522-5536. PubMed ID: 35910791
    [No Abstract]   [Full Text] [Related]  

  • 17. Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies.
    Jena AB; Kanungo N; Nayak V; Chainy GBN; Dandapat J
    Sci Rep; 2021 Jan; 11(1):2043. PubMed ID: 33479401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
    Brown EEF; Rezaei R; Jamieson TR; Dave J; Martin NT; Singaravelu R; Crupi MJF; Boulton S; Tucker S; Duong J; Poutou J; Pelin A; Yasavoli-Sharahi H; Taha Z; Arulanandam R; Surendran A; Ghahremani M; Austin B; Matar C; Diallo JS; Bell JC; Ilkow CS; Azad T
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new DNA aptamer which binds to SARS-CoV-2 spike protein and reduces pro-inflammatory response.
    Kim W; Song ES; Lee SH; Yang SH; Cho J; Kim SJ
    Sci Rep; 2024 Mar; 14(1):7516. PubMed ID: 38553521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Guided Development of Bivalent Aptamers Blocking SARS-CoV-2 Infection.
    Rahman MS; Han MJ; Kim SW; Kang SM; Kim BR; Kim H; Lee CJ; Noh JE; Kim H; Lee JO; Jang SK
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.